Shirley Delung

Shirley Delung is a seasoned professional in the biopharmaceutical industry, currently serving as a Senior Key Account Manager for Rare Disease at UCB Biopharma S/A since June 2024. With a strong background in oncology and rare diseases, Shirley has held key positions including Key Account Manager at Recordati Rare Diseases North America, where responsibilities included promoting Sylvant for Idiopathic Multi-centric Castleman Disease. Previous roles include Oncology Sales Specialist at Ipsen, Hospital Account Specialist at Pfizer, and Regional Account Manager at Spectrum Pharmaceuticals, showcasing a robust track record in account management, sales strategy, and KOL development. Shirley's expertise spans various therapeutic areas, including hematology, rheumatology, and oncology, complemented by a BS in Communications from East Tennessee State University.